Diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV - Revaxis®): patient group direction (PGD) template -

Diphtheria, tetanus and inactivated poliomyelitis vaccine (Td/IPV - Revaxis®): patient group direction (PGD) template
Information type: Drug/medicines management
Source: Public Health England
Specialities: Vaccination
Summary
This PGD template supports the administration of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (DTaP/IPV or dTaP/IPV), to individuals from 10 years of age, in line with national recommendations and the routine childhood immunisation programme.
UKMi comment
The template was first published in November 2015. It has been reviewed and updated to add management of cases and contacts. The updated version is valid from 1 November 2017 to 31 October 2019.
Related links: